News from the Trenches · 25 June 2026

The meeting is the experiment

I once walked into a stakeholder meeting holding an account plan I was proud of.

We had read everything we could get our hands on. The budget pressures, the waiting times, the strategic noises coming out of the region, the gap between the guideline and what was actually happening in the clinic. Out of all that we had built a view of where the real opportunity sat, and a way to bring it that worked for the patient, the system and us. It was a good piece of thinking. I believed it.

The clinic lead listened, nodded in the polite way that tells you nothing, and then said one sentence that took the whole thing apart. Not because the analysis was sloppy. Because she knew one fact about how the department actually ran that we could not have known from the outside, and that one fact moved the opportunity somewhere else entirely.

For about three seconds it felt like failure. It was the opposite. That meeting was the most useful half hour of the whole account.

What science actually is

There is a piece of film from 1964 I keep coming back to. Richard Feynman, the physicist, standing in front of a blackboard at Cornell, explaining in under a minute what science really is. No mysticism, no genius, just a method.

“In general we look for a new law by the following process. First we guess it. Then we compute the consequences of the guess to see what would be implied if this law that we guessed is right. Then we compare the result of the computation to nature, with experiment or experience, compare it directly with observation, to see if it works. If it disagrees with experiment, it is wrong. In that simple statement is the key to science.”

Then the line that should be on the wall of every account team. “It does not make any difference how beautiful your guess is. It does not make any difference how smart you are, who made the guess, or what his name is. If it disagrees with experiment, it is wrong.”

Guess. Work out the consequences. Test it against reality. That is the whole of it.

The same three steps, in a clinic instead of a lab

Read that method again and tell me it is not exactly what we do when we build an account opportunity well.

First we guess. We take everything we already know about the account, the strategic and economic pressures, how the place runs day to day, where the science and the system are not meeting, and from all of it we form a hypothesis about where the real opportunity sits. That is the guess. An informed one, built on evidence, but still a guess.

Then we work out the consequences. If this is really the bottleneck, what else would be true? Who would feel it? What would the department be struggling with that we could name out loud and be right about? A good hypothesis predicts things you have not been told yet.

Then we test it against reality. We bring it to the one place it can actually be checked, the conversation with the person who lives inside that system. And we find out, in real time, whether reality agrees.

The account plan is the guess. The meeting is the experiment.

Why this matters more than it sounds

Because most of us were trained to treat the plan as the deliverable. You do the analysis, you build the beautiful slide, and the meeting becomes a place to present it and have it admired. Under that model, being corrected feels like being caught out. So we defend the plan instead of testing it.

Feynman’s whole point is that the beauty of the guess buys you nothing. The plan being wrong is not the embarrassing part of the process. It is the process. A hypothesis that survives contact with the stakeholder is validated. A hypothesis that gets corrected just handed you the one fact you were missing, for free, from the only person who had it. Either way you walk out with something truer than you walked in with.

The version that never gets tested is the one to worry about. The plan that is too polished to put at risk, the meeting run so tightly that nothing the stakeholder says can change the conclusion. That is not rigour. That is a guess nobody ever checked, dressed up as a finding.

A different way to walk in

So the preparation does not change. If anything it matters more, because a weak guess tests poorly. Read the account properly. Build a real point of view about where the opportunity sits, sharp enough that it could be wrong.

What changes is what you do with it in the room. You bring the hypothesis as a hypothesis, not a verdict. Here is what we think is going on in your pathway, here is why. Do you see it the same way? Then you stop talking and let reality answer. The correction, when it comes, is not the meeting going badly. It is the experiment returning a result.

Back to that clinic lead

The sentence that took my plan apart became the account. We rebuilt the opportunity around the fact she had given me, brought the new version back, and that one was right, because she had already told me where the first one was wrong.

I have stopped trying to walk into those meetings with a plan that cannot fail. A plan that cannot fail is a plan that cannot learn. I try to walk in with the best guess I can build, and the nerve to find out in the open whether it holds.

Feynman would have been fine with the first plan being wrong. He would only have minded if I had never let the clinic test it.

Make the guess as good as you can. Then go and find out.

One article a week. In your inbox.

News from the Trenches: access, engagement and account work in pharma. Unsubscribe any time.